2014-01-01, Yılmaz, Enver Demirel, Deveci, ERDEM, Kadıoğlu, HÜSEYİN, Gençe, Ali Görkem, Ünal, Özge, Koçer, Emel, KIRPINAR, İSMET, DEVECİ, ERDEM, KADIOĞLU, HÜSEYİN, KIRPINAR, İSMET

2019-01-01, ÖZTÜRK, AHMET, Şahan, Ebru, MIRÇIK, ALİ BARLAS, DEVECİ, ERDEM, YILMAZ, ONUR, KIRPINAR, İSMET, ÖZTÜRK, AHMET, ŞAHAN, EBRU, MIRÇIK, ALİ BARLAS, DEVECİ, ERDEM, YILMAZ, ONUR, KIRPINAR, İSMET

Objective: Not only white blood cells but also platelets are being considered in inflammatory reactions from now on. Mean platelet volume (MPV) and neutrophil to lymphocyte ratio (NLR) have been shown to change in inflammatory diseases like myocardial infarction, stroke and implicated in psychiatric disorders nowadays. Our first aim is to investigate the relation of MPV and NLR with depression and secondly to assess if they change with the treatment of depression. Methods: Forty-nine patients diagnosed with major depressive disorder (MDD) and hospitalized in a university hospital psychiatry inpatient unit retrospectively included in the study. Control group consisted of 48 hospital workers with no known disease. Complete blood count, Hamilton Depression Rating Scale (HAM-D) and Clinical Global Impression-Severity Scale (CGI-S) scores at admission and at discharge were noted and compared for the patient group. Discussion: MPV of depressed patients was higher than controls. When we look at admission and discharge scores of clinical scales, decrement is statistically significant for both HAM-D and CGI-S. There was decline both in MPV and NLR which were both statistically significant. Conclusion: Decreasing MPV and NLR values with the treatment of depression confirm the involvement of inflammatory processes in the pathophysiology of depression.

2014-04-01, KIRPINAR, İSMET, DEVECİ, ERDEM, ZİHNİ, DEMET, KILIÇ, ALPEREN, KIRPINAR, İSMET, DEVECİ, ERDEM

2019-01-01, DEVECİ, ERDEM, Kocacenk, Tuba, ŞAHAN, EBRU, YILMAZ, ONUR, ÖZTÜRK, AHMET, KIRPINAR, İSMET, DEVECİ, ERDEM, ŞAHAN, EBRU, YILMAZ, ONUR, ÖZTÜRK, AHMET, KIRPINAR, İSMET

2022-08-01, KILIÇ Ö., BOYLU M. E., Karakaya-Erdur S., Suma-Berberoglu M., Gudjonsson G., Young S., Deveci E., KIRPINAR İ., KILIÇ, ÖZGE, BOYLU, MUHAMMED EMİN, DEVECİ, ERDEM, KIRPINAR, İSMET

Objective: We aim to examine infection risk and vaccine status of COVID-19 in attention deficit and hyperactivity disorder and evaluate the impact of demographic, clinical, and COVID-19-related factors on the infection status and behavioral avoidance of COVID-19. Methods: This cross-sectional study assessed adults with attention deficit and hyperactivity disorder recruited from an outpatient psychiatry clinic. Patients and healthy controls completed a survey on sociodemographic data, COVID-19 infection status, and vaccine status. COVID-19 Disease Perception Scale, COVID-19 Avoidance Attitudes Scale, Attitudes toward COVID-19 Vaccine Scale, Adult Attention Deficit and Hyperactivity Disorder Self-report Screening Scale for DSM-5, Adult Attention Deficit and Hyperactivity Disorder Self-Report Scale Symptoms Checklist, Patient Health Questionnaire-9, and State-Trait Anxiety Inventory were applied. Results: Ninety patients and 40 healthy controls participated. Patients did not differ from controls in COVID-19 infection and vaccine status, and behavioral avoidance of COVID-19. No demographic and clinical factor significantly affected the COVID-19 infection status. Patients scored higher than controls in the perception of COVID-19 as contagious (p = 0.038), cognitive avoidance of COVID-19 (p = 0.008), and positive attitudes toward the COVID-19 vaccine (p = 0.024). After adjustment of possible factors, a positive perception of the COVID-19 vaccine and a perception of COVID-19 as dangerous were the two factors significantly affecting behavioral avoidance of COVID-19 [R 2 = 0. 17, F(2) = 13.189, p < 0.0001]. Conclusion: Infection and vaccine status of COVID-19 in patients did not significantly differ from controls. No demographic and clinical factor significantly affected the COVID-19 infection status. Approximately four-fifths of the patients were fully vaccinated as recommended by national and global health organizations. This has increased the knowledge base showing that the COVID-19 vaccine is acceptable and receiving the vaccine is endorsed by ADHD patients. Attention deficit and hyperactivity disorder itself may provoke no kind of mental disturbance in sense of perception of the danger of this disease. Our findings have increased the knowledge base showing that the COVID-19 vaccine is acceptable and the actual practice of receiving the vaccine is endorsed in this population. Our message for practice would be to take into account not only the core symptoms and the comorbidities of the disorder but also the perception of the disease while exploring its link with COVID-19.

2014-11-30, BAKAY, BETÜL, DEVECİ, ERDEM, ZİHNİ, DEMET, DURSUN, ALİ EMRE, ÖZTÜRK, AHMET, KIRPINAR, İSMET, DEVECİ, ERDEM, ÖZTÜRK, AHMET, KIRPINAR, İSMET

2014-11-16, ÖNÜR, NAFİYE SELCAN, BOYRAZ, RABİA KEVSER, KOÇER, EMEL, DEVECİ, ERDEM, KIRPINAR, İSMET, ÖNÜR, NAFIYE SELCAN, BOYRAZ, RABIA KEVSER, DEVECİ, ERDEM, KIRPINAR, İSMET

2014-09-01, Ozturk, AHMET, Deveci, ERDEM, DURSUN, Ali Emre, Soyucok, Etem, Kirpinar, Ismet, DEVECİ, ERDEM, KIRPINAR, İSMET

2013-11-03, YILMAZ, ENVER DEMİREL, DEVECİ, ERDEM, GÜLEÇ, HÜSEYİN, KIRPINAR, İSMET, DEVECİ, ERDEM, KIRPINAR, İSMET

2014-11-01, DEVECİ, ERDEM, ÖZTÜRK, AHMET, KIRPINAR, İSMET, KOYUNCU, AHMET, ENGİN, İSMAİL, MELİKOĞLU, MEHMET, YILMAZ, ENVER DEMİREL, KOÇER, EMEL, DEVECİ, ERDEM, ÖZTÜRK, AHMET, KIRPINAR, İSMET